[2] Dose titration and monitoring Juniper follows the standard 16-week titration schedule used in the STEP clinical trial program: 0.25 mg weekly for weeks 1-4, 0.5 mg for weeks 5-8, 1.0 mg for weeks 9-12, 1.7 mg for weeks 13-16, then 2.4 mg maintenance
Clinical trials, media reports, or search trends do not mean that an active ingredient is already approved, available in Germany, or medically suitable
Quality assessment Potential risks of bias were evaluated for all included trials, using a tool for randomised trials (RoB 2) developed for this purpose.13 This tool assesses bias in five different domains: bias arising from the randomisation, bias due to deviations from the intended intervention, bias due to missing outcome data, bias in the measurement of the outcome and bias in the selection of the reported result
These include: type of peptide used dosage and treatment duration clinic expertise geographic location Insurance Coverage Most peptide therapies are considered wellness or regenerative treatments
doi:10.7759/cureus.75304 27